BLAST Therapeutics Inc. is a specialty, development-stage biomaterials company focused
on developing materials that accelerate bone repair and regeneration to improve patient care. The technology, developed at
The Institute for Regenerative Medicine at Texas A&M University provides a platform technology based on the indentification
and characterization of two classes of bone marrow stem cells, as well as unique methods to condition these cells to increase
their propensity for making bone.